Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
ALEXION PHARMACEUTICALS, INC. (ALXN) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/22/2021 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of Alexion Pharmaceuticals Inc.",
"Amended and Restated Bylaws of Alexion Pharmaceuticals Inc."
07/20/2021 8-K Results of Operations and Financial Condition  Interactive Data
05/11/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
04/30/2021 8-K Quarterly results
03/15/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
02/04/2021 8-K Quarterly results
01/12/2021 8-K Quarterly results
12/14/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement and Plan of Merger, by and among AstraZeneca PLC, Delta Omega Sub Holdings Inc., Delta Omega Sub Holdings Inc. 1, Delta Omega Sub Holdings LLC 2, and Alexion Pharmaceuticals, Inc",
"Greater scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline Dedicated rare disease unit to be headquartered in Boston"
10/29/2020 8-K Quarterly results
Docs: "Alexion Reports Third Quarter 2020 Results"
10/01/2020 8-K Quarterly results
08/25/2020 8-K Quarterly results
07/30/2020 8-K Quarterly results
07/02/2020 8-K Quarterly results
05/29/2020 8-K Entry into a Material Definitive Agreement  Interactive Data
05/19/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/07/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER by and among PORTOLA PHARMACEUTICALS, INC., ALEXION PHARMACEUTICALS, INC. and Odyssey Merger Sub Inc."
05/06/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
01/30/2020 8-K Quarterly results
Docs: "Alexion Reports Fourth Quarter and Full Year 2019 Results"
01/28/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "CONTINGENT VALUE RIGHTS AGREEMENT Dated as of among Alexion Pharmaceuticals, Inc. and Computershare Inc. as Rights Agent B5092239.1",
"Alexion Completes Acquisition of Achillion – Acquisition adds two clinical-stage Factor D inhibitors to Alexion’s pipeline and provides promising development platform for additional complement-mediated diseases –"
01/13/2020 8-K Investor presentation
Docs: "HUS, NMOSD, HSCT-TMA, ALS, PPMS"
10/23/2019 8-K Quarterly results
10/21/2019 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "B L U E B E L L 2"
10/16/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement and Plan of Merger, by and among Alexion, Beagle Merger Sub, Inc. and Achillion",
"Agreement and Plan of Merger, by and among Alexion, Beagle Merger Sub, Inc. and Achillion",
"Alexion to Acquire Achillion",
"Investor Presentation"
09/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/05/2019 8-K Other Events  Interactive Data
07/24/2019 8-K Quarterly results
Docs: "Alexion Reports Second Quarter 2019 Results"
05/17/2019 8-K Submission of Matters to a Vote of Security Holders
04/25/2019 8-K Quarterly results
Docs: "Alexion Reports First Quarter 2019 Results"
02/04/2019 8-K Quarterly results
12/21/2018 8-K Regulation FD Disclosure
11/16/2018 8-K Regulation FD Disclosure
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy